Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL-10: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Interleukin-10 (IL-10) — an anti-inflammatory cytokine that modulates neuroinflammation in Alzheimer's and Parkinson's disease through JAK-STAT3 signaling.
No AI portrait yet
| Gene Symbol | IL |
| Function | Interleukin-1 beta (IL-1β) is a potent pro-inflammatory cytokine that plays a central role in the innate immune response and neuroinflammation. |
| GeneCards | IL |
| Human Protein Atlas | IL |
| Associated Diseases | CRC |
| KG Connections | 1 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
IL10["IL-10"]
S1P1["S1P1 Receptor"]
TNF["TNF-alpha"]
IL6["IL-6"]
AKT["AKT"]
NRF2["Nrf2"]
MICROGLIA["Microglia"]
NEUROINFLAM["Neuroinflammation"]
INFLAM["Inflammation"]
SPHINGO["Sphingolipid Metabolism"]
APOPTOSIS["Apoptosis"]
ALZHEIMER["Alzheimer's Disease"]
PARKINSON["Parkinson's Disease"]
AMYLOID["Amyloid Beta"]
LRRK2["LRRK2"]
PARKIN["Parkin"]
S1P1 -->|"upregulates"| IL10
AKT -->|"promotes"| IL10
NRF2 -->|"enhances"| IL10
MICROGLIA -->|"produces"| IL10
TNF -->|"inhibits"| IL10
IL6 -->|"inhibits"| IL10
AMYLOID -->|"suppresses"| IL10
IL10 -->|"inhibits"| NEUROINFLAM
IL10 -->|"suppresses"| INFLAM
IL10 -->|"regulates"| SPHINGO
IL10 -->|"protects against"| APOPTOSIS
NEUROINFLAM -->|"contributes to"| ALZHEIMER
NEUROINFLAM -->|"contributes to"| PARKINSON
LRRK2 -->|"associated with"| PARKINSON
PARKIN -->|"associated with"| PARKINSON
style IL10 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px
style S1P1 fill:#1b5e20,stroke:#333,stroke-width:2px
style AKT fill:#4a1a6b,stroke:#333,stroke-width:2px
style NRF2 fill:#4a1a6b,stroke:#333,stroke-width:2px
style TNF fill:#ef5350,stroke:#333,stroke-width:2px
style IL6 fill:#ef5350,stroke:#333,stroke-width:2px
style NEUROINFLAM fill:#ef5350,stroke:#333,stroke-width:2px
style INFLAM fill:#ef5350,stroke:#333,stroke-width:2px
style ALZHEIMER fill:#7d4200,stroke:#333,stroke-width:2px
style PARKINSON fill:#7d4200,stroke:#333,stroke-width:2px
style MICROGLIA fill:#1b5e20,stroke:#333,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | inhibits | process | 0.95 |
| Sphingolipid Metabolism | inhibits | pathway | 0.95 |
| Sphingolipid Metabolism | modulates | pathway | 0.90 |
| Sphingolipids | regulates | compound | 0.90 |
| microglia | expressed_in | cell_type | 0.85 |
| TGF | activates | gene | 0.85 |
| unfolded protein response | participates_in | pathway | 0.85 |
| TGF-beta signaling | participates_in | pathway | 0.85 |
| neurotrophin signaling | participates_in | pathway | 0.85 |
| sphingolipid metabolism | associated_with | process | 0.80 |
| Psoriasis | associated_with | disease | 0.80 |
| inflammation | associated_with | disease | 0.80 |
| MACROPHAGES | activates | cell_type | 0.80 |
| Neuroinflammation | inhibits | process | 0.80 |
| NF-kB signaling | participates_in | pathway | 0.75 |
| astrocytes | expressed_in | cell_type | 0.75 |
| MONOCYTE | promotes | cell_type | 0.65 |
| Ms | causes | disease | 0.65 |
| MACROPHAGE | promotes | cell_type | 0.65 |
| TGF | biomarker_for | gene | 0.65 |
| Inflammation | causes | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| oxidative stress response | participates_in | pathway | 0.65 |
| TNF | inhibits | gene | 0.65 |
| Tumor | degrades | disease | 0.65 |
| Multiple Sclerosis | expressed_in | disease | 0.65 |
| TNF | causes | gene | 0.65 |
| TNF | biomarker_for | gene | 0.65 |
| IL-6 | causes | gene | 0.65 |
| Als | expressed_in | disease | 0.65 |
| ROS | causes | gene | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| MICROGLIA | associated_with | cell_type | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| neuroinflammation | activates | disease | 0.65 |
| Multiple Sclerosis | biomarker_for | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neuroinflammation | biomarker_for | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Parkinson | expressed_in | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Lymphoma | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 0.98 |
| LRWE | upregulates | compound | 0.90 |
| TNF | inhibits | gene | 0.90 |
| 32505187 | was reduced in | paper | 0.90 |
| S1P1 | upregulates | receptor | 0.85 |
| MICROGLIA | associated_with | cell_type | 0.82 |
| IL-6 | inhibits | gene | 0.82 |
| AMYLOID | associated_with | protein | 0.82 |
| PARKINSON'S DISEASE | associated_with | disease | 0.82 |
| IL-6 | associated_with | gene | 0.82 |
| DHT | upregulates | compound | 0.80 |
| TREM2 | regulated_by | gene | 0.78 |
| DHT | modulates | compound | 0.75 |
| CD68 | activates | gene | 0.75 |
| GDNF | activates | gene | 0.75 |
| MICROGLIA | inhibits | cell_type | 0.74 |
| TNF | activates | gene | 0.66 |
| IL-6 | activates | gene | 0.66 |
| TNF | associated_with | gene | 0.66 |
| HDAC | activates | gene | 0.65 |
| ASTROCYTES | promotes | cell_type | 0.65 |
| CD38 | promotes | gene | 0.65 |
| GFAP | promotes | gene | 0.65 |
| ASTROCYTE | promotes | cell_type | 0.65 |
| CREB | activates | gene | 0.65 |
| CX3CR1 | regulates | gene | 0.65 |
| BDNF | causes | gene | 0.65 |
| ATP | interacts_with | gene | 0.65 |
| NF-KB | associated_with | protein | 0.64 |
| BAX | associated_with | gene | 0.64 |
| AKT | associated_with | gene | 0.64 |
| P2X7 | activates | gene | 0.60 |
| GAIN | regulates | gene | 0.60 |
| IL1R1 | activates | gene | 0.60 |
| SYK | inhibits | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| IL-1 | associated_with | gene | 0.60 |
| NLRP3 | associated_with | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| ASC | activates | gene | 0.60 |
| COMPLEMENT | activates | gene | 0.60 |
| CD68 | expressed_in | gene | 0.60 |
| LRRK2 | activates | gene | 0.60 |
| GLIOBLASTOMA | activates | gene | 0.60 |
| NAD | inhibits | gene | 0.60 |
| NAMPT | inhibits | gene | 0.60 |
| CD38 | activates | gene | 0.60 |
| SIRT6 | inhibits | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral | 0.648 | neuroinflammation | How do B cells mechanistically orchestra |
| CCR2+ Monocyte Reprogramming via IL-10 Enhancement for CNS I | 0.000 | immunomics | Systemic immune profiling in neurodegene |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.990
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| IL-10 deficiency and VLC ceramide accumulation in inflammatory bowel d | validation | inflammatory bowel disease | 0.900 | 0.00 | IL-10 knockout mice | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.92 · 2026-04-26
Hypotheses and analyses mentioning IL-10 in their description or question text
No additional research found